263 related articles for article (PubMed ID: 19014942)
21. Decreased circulating iNKT cell numbers in refractory coeliac disease.
Bernardo D; van Hoogstraten IM; Verbeek WH; Peña AS; Mearin ML; Arranz E; Garrote JA; Scheper RJ; Schreurs MW; Bontkes HJ; Mulder CJ; von Blomberg BM
Clin Immunol; 2008 Feb; 126(2):172-9. PubMed ID: 17974485
[TBL] [Abstract][Full Text] [Related]
22. Continual monitoring of intraepithelial lymphocyte immunophenotype and clonality is more important than snapshot analysis in the surveillance of refractory coeliac disease.
Liu H; Brais R; Lavergne-Slove A; Jeng Q; Payne K; Ye H; Liu Z; Carreras J; Huang Y; Bacon CM; Hamoudi RA; Save V; Venkatraman L; Isaacson PG; Woodward J; Du MQ
Gut; 2010 Apr; 59(4):452-60. PubMed ID: 19996326
[TBL] [Abstract][Full Text] [Related]
23. High rates of complications and substantial mortality in both types of refractory sprue.
Daum S; Ipczynski R; Schumann M; Wahnschaffe U; Zeitz M; Ullrich R
Eur J Gastroenterol Hepatol; 2009 Jan; 21(1):66-70. PubMed ID: 19011576
[TBL] [Abstract][Full Text] [Related]
24. Is refractory celiac disease more severe in old Europe?
Malamut G; Cellier C
Am J Gastroenterol; 2011 May; 106(5):929-32. PubMed ID: 21540899
[TBL] [Abstract][Full Text] [Related]
25. Flow cytometric analysis of intestinal intraepithelial lymphocytes in the diagnosis of refractory celiac sprue.
Sanchez-Muñoz LB; Santón A; Cano A; Lopez A; Almeida J; Orfao A; Escribano L; Roy G
Eur J Gastroenterol Hepatol; 2008 May; 20(5):478-87. PubMed ID: 18403953
[TBL] [Abstract][Full Text] [Related]
26. Refractory celiac disease: from bench to bedside.
Malamut G; Meresse B; Cellier C; Cerf-Bensussan N
Semin Immunopathol; 2012 Jul; 34(4):601-13. PubMed ID: 22810901
[TBL] [Abstract][Full Text] [Related]
27. Flow cytometry for the assessment and monitoring of aberrant intraepithelial lymphocytes in non-responsive celiac disease and non-celiac enteropathies.
Schiepatti A; Maimaris S; Scarcella C; Pignatti P; Betti E; Shoval Y; Arpa G; Ciccocioppo R; Biagi F
Dig Liver Dis; 2024 May; 56(5):795-801. PubMed ID: 37968145
[TBL] [Abstract][Full Text] [Related]
28. Refractory celiac disease.
Malamut G; Cellier C
Expert Rev Gastroenterol Hepatol; 2014 Mar; 8(3):323-8. PubMed ID: 24502536
[TBL] [Abstract][Full Text] [Related]
29. The management of complicated celiac disease.
Al-toma A; Verbeek WH; Mulder CJ
Dig Dis; 2007; 25(3):230-6. PubMed ID: 17827946
[TBL] [Abstract][Full Text] [Related]
30. Investigation of molecular markers in the diagnosis of refractory coeliac disease in a large patient cohort.
O'Shea U; Abuzakouk M; O'Morain C; O'Donoghue D; Sheahan K; Watson P; O'Briain S; Alexander D; Catherwood M; Jackson J; Kelly J; Feighery C
J Clin Pathol; 2008 Nov; 61(11):1200-2. PubMed ID: 18955575
[TBL] [Abstract][Full Text] [Related]
31. Refractory Celiac Disease.
Malamut G; Cellier C
Gastroenterol Clin North Am; 2019 Mar; 48(1):137-144. PubMed ID: 30711206
[TBL] [Abstract][Full Text] [Related]
32. Refractory celiac disease.
Malamut G; Murray JA; Cellier C
Gastrointest Endosc Clin N Am; 2012 Oct; 22(4):759-72. PubMed ID: 23083992
[TBL] [Abstract][Full Text] [Related]
33. Update on the management of refractory coeliac disease.
Al-Toma A; Verbeek WH; Mulder CJ
J Gastrointestin Liver Dis; 2007 Mar; 16(1):57-63. PubMed ID: 17410290
[TBL] [Abstract][Full Text] [Related]
34. Refractory celiac disease.
Rishi AR; Rubio-Tapia A; Murray JA
Expert Rev Gastroenterol Hepatol; 2016; 10(4):537-46. PubMed ID: 26603931
[TBL] [Abstract][Full Text] [Related]
35. Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor.
Louvet A; Wartel F; Castel H; Dharancy S; Hollebecque A; Canva-Delcambre V; Deltenre P; Mathurin P
Gastroenterology; 2009 Aug; 137(2):541-8. PubMed ID: 19445945
[TBL] [Abstract][Full Text] [Related]
36. Predictors of corticosteroid-dependent and corticosteroid-refractory inflammatory bowel disease: analysis of a Chinese cohort study.
Chow DK; Sung JJ; Tsoi KK; Wong VW; Wu JC; Leong RW; Chan FK
Aliment Pharmacol Ther; 2009 Apr; 29(8):843-54. PubMed ID: 19154567
[TBL] [Abstract][Full Text] [Related]
37. Clinical Insignficance of Monoclonal T-Cell Populations and Duodenal Intraepithelial T-Cell Phenotypes in Celiac and Nonceliac Patients.
Celli R; Hui P; Triscott H; Bogardus S; Gibson J; Hwang M; Robert ME
Am J Surg Pathol; 2019 Feb; 43(2):151-160. PubMed ID: 30334829
[TBL] [Abstract][Full Text] [Related]
38. Immunophenotypic Spectrum and Genomic Landscape of Refractory Celiac Disease Type II.
Soderquist CR; Lewis SK; Gru AA; Vlad G; Williams ES; Hsiao S; Mansukhani MM; Park DC; Bacchi CE; Alobeid B; Green PH; Bhagat G
Am J Surg Pathol; 2021 Jul; 45(7):905-916. PubMed ID: 33544565
[TBL] [Abstract][Full Text] [Related]
39. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
[TBL] [Abstract][Full Text] [Related]
40. Azathioprine and prednisone combination therapy in refractory coeliac disease.
Goerres MS; Meijer JW; Wahab PJ; Kerckhaert JA; Groenen PJ; Van Krieken JH; Mulder CJ
Aliment Pharmacol Ther; 2003 Sep; 18(5):487-94. PubMed ID: 12950421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
